White House releases statement on at-home COVID-19 testing, potential cost implications - Bim Group

White House releases statement on at-home COVID-19 testing, potential cost implications

SOURCE: UnitedHealthcare


On Dec. 2, 2021, the White House released a statement announcing several actions to fight COVID-19, including requiring commercial health plans to cover COVID-19 at-home tests – approved or authorized by the Food and Drug Administration (FDA) – without cost-sharing. The White House has directed the Tri-Agencies (Departments of Health and Human Services, Labor and the Treasury) to issue guidance implementing this policy by Jan. 15, 2022.

The following information has been conveyed through the statement and press announcement:

  • The requirements will likely apply to fully insured, level-funded and self-funded group plans, including grandfathered and transitional relief business and business through the Exchanges.
  • The Administration preliminarily indicated the coverage requirements would not apply retroactively and would only provide coverage for diagnostic tests, as the current requirement stipulates.
  • Any requirements would likely extend through the Public Health Emergency.

UnitedHealthcare regulatory, clinical, actuarial, operations and COVID-19 testing teams are working to address and respond to the guidance when it is released.

The guidance is expected to impact 2022 health care spending. For example, at an average cost of $25 for 2 tests, and 6 tests submitted per member in 2022, the additional cost per member would be $75.

UnitedHealthcare will provide input to the Administration on how to best implement this new policy in a manner that balances access with affordability and patient safety.

Please contact your broker or UnitedHealthcare representative if you have questions or would like to learn more about advocacy efforts.

Recent Insights

May 19, 2023

Webinar: Navigate Your Way Through FMLA

Tuesday, June 13, 2023 1 – 2PM CST Register Now Attend this month’s webinar to learn how to recognize if you are a covered employer, which employees are eligible, and qualifying reasons for Family and Medical Leave (FMLA). Gain insights into: Regulations surrounding mental health and substance abuse leave Managing benefits during FMLA leave Coordination […]
Read more
May 17, 2023

April 2023 Compliance Recap

READ TIME: 4 MINUTES While the compliance focus for April continues to be on the Prescription Drug Data Collection (RxDC) of the Consolidated Appropriations Act, 2021, the Centers for Medicare and Medicaid Services (CMS) released a Fact Sheet announcing the 2024 benefit parameters for Medicare Part D. 2024 Benefit Parameters for Medicare Part D Creditable […]
Read more
May 17, 2023

Update on the End of the COVID-19 National Emergency and Public Health Emergency

READ TIME: 5 MINUTES In January 2023, the Biden administration announced its intent to end the COVID-19 national emergency and the COVID-19 public health emergency effective May 11, 2023, directly impacting the coverage of certain COVID-19 services as well as the timeframes for participants for certain health plan-related deadlines, such as special enrollment, COBRA election, […]
Read more
April 26, 2023

DOL Signals July 10 as End of COVID-19 Outbreak Period, Despite Early End to National Emergency

READ TIME: 6 MINUTES On Monday, April 10, 2023, President Biden signed Congress’s jointly-introduced H.J Res. 7 into law, ending the COVID-19 National Emergency immediately instead of on May 11, 2023, as previously announced. However, the Department of Labor (DOL) has unofficially signaled that its previous guidance issued on March 29, 2023, stands, including guidance […]
Read more